Legal Representation
Attorney
Aisling E. Altidore
USPTO Deadlines
Next Deadline
1098 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-12)
Due Date
July 12, 2028
Grace Period Ends
January 12, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 17, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Nov 7, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Oct 18, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED |
Oct 18, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Oct 12, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Jul 12, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jul 12, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
May 9, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Apr 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 13, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Apr 13, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Apr 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 30, 2022 | ATRV | O | ATTORNEY REVIEW COMPLETED |
Mar 25, 2022 | LIME | X | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
Mar 22, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Mar 22, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Mar 22, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Mar 22, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Mar 22, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 12, 2022 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB |
Feb 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 23, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 26, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Jan 26, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 26, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jan 26, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jan 26, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Oct 4, 2021 | RFNT | P | REFUSAL PROCESSED BY IB |
Sep 13, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU |
Sep 13, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Sep 1, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Aug 31, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 27, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 23, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Mar 19, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 18, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Nutraceuticals for use as a dietary supplement mainly based on processed vegetables and processed fruits; nutraceuticals for use as a dietary supplement mainly based on cereals; health food supplements made principally of minerals; powdered nutritional supplement drink mixes; dietetic substances adapted for medical purposes consisting of vitamins, minerals, amino acids and trace elements; health food supplements made principally of vitamins; crude medicines for treating vaginal diseases; dietary supplements; nutraceuticals for use as dietary supplements; dietary fiber for treating constipation or aiding digestion; dietary supplements consisting of amino acids, minerals and trace elements; ferments for pharmaceutical purposes; nutraceuticals for use as a dietary supplement mainly based on lactic acid bacteria; food supplements mainly based on lactic acid bacteria for medical purposes; nutraceuticals for use as a dietary supplement mainly based on lactic acid bacteria for health of vagina of woman; antibacterial substances in the nature of antibacterial soaps and pharmaceuticals for medical purposes; medicinal lactic acid bacteria preparations; multivitamins; nutraceuticals for use as a dietary supplement mainly based on vegetable extracts; dietary supplements for controlling cholesterol
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005